CVR 46390369Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)FrederiksbergFounded 7 Apr 2026
Employees
1
CVR, Aug 2026
CVR holds no annual report for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about CaMaRa ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexNovo Holdings A/SCVR 24257630, 25% to under 33.3% of capital and votes
ForDD Ventures VIII B.V.25% to under 33.3% of capital and votes
and 2 moreOperating company
Dandex estimate: 1 employee registered in 2026Peter Høngård Andersensince 29 May 2026
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 2425763025% to under 33.3% of capital and votesclass Præferenceanparternotified 31 Jul 2026since 29 May 2026
15% to under 20% of capital and votesclass Præferenceanparternotified 31 Jul 2026since 29 May 2026
15% to under 20% of capital and votesclass Præferenceanparternotified 31 Jul 2026since 29 May 2026
25% to under 33.3% of capital and votesclass Præferenceanpartersince 31 Jul 2026
CVR 41222182100% of capital and votesnotified 29 May 20267 Apr 2026 to 29 May 2026
5% to under 10% of capital and votesclass Ordinære anparter29 May 2026 to 31 Jul 2026
5% to under 10% of capital and votesclass Ordinære anparter29 May 2026 to 31 Jul 2026
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 1 employee, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|
| Employees | 1 | 1 | 1 |
| FTE | 0 | 0 | 0 |
| Series | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for CaMaRa ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 14,951,200, cash price 299.02, implied value 59,804,800 | 299.02 | 14,951,200 | 59,804,800 | 200,000 | |
| IncreaseCashPaid in 44,847,595, cash price 344.98, implied value 51,747,225 | 344.98 | 44,847,595 | 51,747,225 | 150,000 | |
| FoundingCashPaid in 20,000 | None | 20,000 | None | 20,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
4 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 31.07.2026
Kapitalforhøjelsen er besluttet den 31.07.2026.
kr. 50.000,00, indbetalt kontant, kurs 29.902,40.
Kapitalen udgør herefter kr. 200.000,00.
Vedtægter ændret: 29.05.2026
Kapitalforhøjelsen er besluttet den 29.05.2026.
kr. 130.000,00, indbetalt kontant, kurs 34.498,15.
Kapitalen udgør herefter kr. 150.000,00.
Kapitalen er opdelt i klasser.
Bestyrelse:
Fratrådte:
Peter Høngård Andersen, (formand), den 29.05.2026.
Tiltrådte:
Peter Høngård Andersen, den 29.05.2026, Mads Peter Hemmingsen, den 29.05.2026, Edward Timothy Mathers, den 29.05.2026, John Gary Montana, (formand), den 29.05.2026, Marco Boorsma, den 29.05.2026, Melina Christine Claussnitzer, den 29.05.2026, Nandita Shangari Batra, den 29.05.2026.
Direktion:
Fratrådte:
Thomas Gundelund Rasmussen, (adm. dir), den 29.05.2026, John Gary Montana, den 29.05.2026.
Tiltrådte:
Peter Høngård Andersen, (adm. dir), den 29.05.2026.
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af en direktør i forening med bestyrelsesformanden, eller af den samlede bestyrelse.
Revision:
Tiltrådte:
CVR-NR. 30700228 EY Godkendt Revisionspartnerselskab, Dirch Passers Allé 36, 2000 Frederiksberg, den 29.05.2026.
Formål ændret: Selskabets formål er at identificere og vurdere aktiver og mål, levering af relaterede rådgivnings- og serviceydelser og anden i forbindelse hermed stående virksomhed.
Ny adresse: c/o Symbion Frederiksberg, Nordre Fasanvej 215, 2000 Frederiksberg
Stiftelsesdato: 07.04.2026.
Virkningsdato: 07.04.2026.
Seneste vedtægtsdato: 07.04.2026.
Kapital:
kr. 20.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 20.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 41222182 Origem Holding ApS, Ledreborg Alle 3, 2820 Gentofte, den 07.04.2026.
Bestyrelse:
Peter Høngård Andersen, (formand), den 07.04.2026.
Direktion:
Thomas Gundelund Rasmussen, (adm. dir), den 07.04.2026, John Gary Montana, den 07.04.2026.
Virksomheden tegnes af en direktør alene
Første regnskabsår:
07.04.2026 - 31.12.2026.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er forskning, udvikling, produktion og salg af lægemidler og andre beslægtede forretningsområder efter bestyrelsens skøn.
P-number 1032294398Nordre Fasanvej 215, 2000 Frederiksberg
No other current company drawn.
No other current company drawn.
No other current company drawn.